Frontiers in Endocrinology (Mar 2019)

Age Induced Nitroso-Redox Imbalance Leads to Subclinical Hypogonadism in Male Mice

  • John Alden Lee,
  • Manish Kuchakulla,
  • Himanshu Arora,
  • Himanshu Arora,
  • Shathiyah Kulandavelu,
  • Evert Gonzalez,
  • Thomas A. Masterson,
  • Joshua M. Hare,
  • Ursula B. Kaiser,
  • Ranjith Ramasamy,
  • Ranjith Ramasamy

DOI
https://doi.org/10.3389/fendo.2019.00190
Journal volume & issue
Vol. 10

Abstract

Read online

Objective: The cause of age-related changes in testosterone remains unclear. We hypothesized that increased nitroso-redox imbalance with aging could affect testosterone production.Materials and Methods: We measured several markers of nitroso-redox imbalance (4-HNE, 3-NT, and NT) in serum of S-nitrosoglutathione reductase knock out (GSNOR KO) mice that have increased nitroso-redox imbalance and compared these to wild-type (WT) mice. We evaluated the impact of age-induced nitroso-redox imbalance on serum luteinizing hormone (LH) and testosterone (T) in WT young (<2 months), middle-aged (2–6 months), and aged (>12 months) mice. Finally, to elucidate the susceptibility of testes to nitroso-redox imbalance, we measured 4-HNE protein levels in the testes of WT and KO mice.Results: We identified 4-HNE as a reliable marker of nitroso-redox imbalance, as evidenced by increased protein levels in serum of GSNOR KO mice compared with WT mice. We demonstrated that 4-HNE serum protein levels increase in WT mice with age but do not accumulate in the testes. We also found that T levels were similar in all age groups. Interestingly, we found that serum LH levels in aged and middle-aged mice were increased when compared to young mice (n = 5) consistent with the phenotype of subclinical hypogonadism.Conclusions: Increased serum 4-HNE and LH levels without changes in T with age suggest that nitroso-redox imbalance is associated with subclinical hypogonadism in aged mice. Recognizing the relationship and etiology of a currently poorly understood classification of hypogonadism could be a paradigm shift in how age-related testosterone change is diagnosed and treated.

Keywords